Arpa Garay is Chief Commercial Officer of Moderna, Inc.. Currently has a direct ownership of 3,690 shares of MRNA, which is worth approximately $319,738. The most recent transaction as insider was on Dec 06, 2023, when has been sold 564 shares (Common Stock) at a price of $78.34 per share, resulting in proceeds of $44,183. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.69K
0% 3M change
44.88% 12M change
Total Value Held $319,738

Arpa Garay Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 06 2023
SELL
Open market or private sale
$44,183 $78.34 p/Share
564 Reduced 13.26%
3,690 Common Stock
Dec 05 2023
BUY
Exercise of conversion of derivative security
-
1,141 Added 21.15%
4,254 Common Stock
Sep 06 2023
SELL
Open market or private sale
$62,221 $108.4 p/Share
574 Reduced 15.57%
3,113 Common Stock
Sep 05 2023
BUY
Exercise of conversion of derivative security
-
1,140 Added 23.62%
3,687 Common Stock
Jun 06 2023
SELL
Open market or private sale
$287,967 $125.75 p/Share
2,290 Reduced 47.34%
2,547 Common Stock
Jun 05 2023
BUY
Exercise of conversion of derivative security
-
4,562 Added 48.54%
4,837 Common Stock

Also insider at

MRK
Merck & Co., Inc. Healthcare
AG

Arpa Garay

Chief Commercial Officer
Kenilworth, NJ

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Track Activities on MRNA